Clinical Evidence HIV patients: 26-week trials show 20% reduction in abdominal fat Metabolic syndrome patients: Improvements in triglycerides, liver fat, and insulin sensitivity Ideal Candidates for Tesamorelin People with visceral obesity Patients with metabolic syndrome or insulin resistance Individuals able to commit to daily injections and lab monitoring Ipamorelin: Gentle Growth Hormone Booster Ipamorelin is a selective ghrelin receptor agonist that stimulates GH without significantly affecting cortisol, prolactin, or ACTH
Our expert team, led by Dr
Abstract Depression has emerged as a major cause of mortality globally
Across compounds, the variability in dosing regimens, developmental timing, behavioral assays, and redox endpoints impose interpretive caution and require harmonization for future translational work
This formulation combines three peptides that have been studied in preclinical models for their roles in tissue repair processes
Mattanovich D, Sauer M, Gasser B